Navigate Fool.com
Will OSIR beat
the market?

Osiris Therapeutics, Inc. (NASDAQ: OSIR)

Community Rating: 1 Star: Ominous

14.72 0.20 (1.38%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.40
Previous Close $14.52
Daily Range $14.34 - $14.78
52-Week Range $10.05 - $27.40
Market Cap $503.8M
P/E Ratio -290.40
Dividend (Yield) $0.00 (0.0%)
Volume 132,445
Average Daily Volume 165,834
Current FY EPS $0.09

How do you think OSIR
will perform against the market?

Top OSIR Bull/Bear Pitches


riskybus (3.91)
Submitted July 8, 2008

"Osiris was the God who made the seeds ripe for the harvesting, and also could raise those from the dead."

1 Replies Reply Report this Post

zzlangerhans (< 20)
Submitted March 1, 2013

I had to take a nine month hiatus from rating Osiris after the stock executed a quick double after my last red thumb for reasons I'll never comprehend. The market yawned when Prochymal was approved in … More

1 Replies Reply Report this Post

News & Commentary

Why Osiris Theraputics Inc. Shares Soared

Is this meaningful? Or just another movement?

Pre-Market Earnings Report for May 13, 2014 : ECA, INSY, REN, OSIR, VTNR, AHH, IDRA, TGTX, OMEX, DC

Pre-Market Earnings Report for May 13, 2014 : ECA, INSY, REN, OSIR, VTNR, AHH, IDRA, TGTX, OMEX, DCIX, ZFC, SSH

Commit To Purchase Osiris Therapeutics At $11, Earn 16% Annualized Using Options

3 Ways 3-D Bioprinting Can Disrupt the Health-Care Industry

Will 3-D bioprinting technology from companies such as Organovo disrupt older technologies from Boston Scientific, Osiris Therapeutics, and Hanger?

Why Osiris Therapeutics Inc. Shares Tanked

Shareholders react negatively to the departure of an important piece of the Osiris Therapeutics puzzle.

3 Biggest Biotech Winners Last Week

3 health care stocks that were on the rise last week: Idenix Pharmaceuticals Inc (Nasdaq: IDIX), Osiris Therapeutics, Inc. (Nasdaq: OSIR), and Dyax Corp. (Nasdaq: DYAX).

3 Humongous Health-Care Stocks This Week

Which health-care stocks raked in the most treats for investors this Halloween week? Dyax, Idenix, and Osiris delivered the goodies big-time.

Why Osiris Therapeutics Inc. Shares Spiked Higher

Osiris reports its third-quarter results, and investors like what they see. Is this the time to jump on board or has this train long left the station?

This Week in Biotech

A surprise FDA approval, positive early-stage pancreatic cancer trial results, and a unanimous FDA panel recommendation for what could be a $7 billion drug are among this week's top biotech stories.

This Biotech Trifecta Could Revolutionize Cancer

A new partnership between Intrexon, Mesoblast, and Ziopharm aims to develop a new class of novel cancer therapeutics.

See More OSIR News...





Osiris Therapeutics, Inc. (OSIR) Description

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas. Website: http://www.osiristx.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks